𝔖 Bobbio Scriptorium
✦   LIBER   ✦

5-HT3Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting

✍ Scribed by R. Elizabeth Gregory, Professor David S. Ettinger

Book ID
119926958
Publisher
Springer International Publishing AG
Year
1998
Tongue
English
Weight
314 KB
Volume
55
Category
Article
ISSN
0012-6667

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase I study of a new 5HT3-receptor a
A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting
✍ Geoffrey Falkson; Adriaan J. Zyl πŸ“‚ Article πŸ“… 1989 πŸ› Springer 🌐 English βš– 370 KB

In a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 micrograms/kg was given to 24 patients. All patients received cytostatic treatment expected to cause nausea and vomiting. During the first 24 h, 12 patients were completely protected from nausea and vomiting, 4 experien

High versus low dose granisetron, a sele
High versus low dose granisetron, a selective 5HT3antagonist, for the prevention of chemotherapy-induced nausea and vomiting
✍ H. C. Falkson; C. I. Falkson; G. Falkson πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 173 KB

Fifty six patients, with histologically confirmed cancer, who received highly emetogenic chemotherapy, were entered on a randomized double blind, low versus high dose, study of granisetron, a 5HT3 receptor antagonist. A single dose of intravenous granisetron protected the majority of patients from n